Pyrovalerone hydrochloride

tert-butyl 4-(1H-pyrrolo[3,2-b]pyridin-7-yl)cyclohexanecarboxylate.

p53-MDM2 inhibitors: Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction: inhibitors of interaction of p53-MDM2/X protein:.

p53-MDM2 inhibitors: Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction: inhibitors of interaction of p53-MDM2/X protein:.

p53-MDM2 inhibitors: Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction: inhibitors of interaction of p53-MDM2/X protein:.

Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 uM and 0.8 uM respectively.A pyridazinone derivative and a selective inhibitor of phosphodiesterase type III and IV.

Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 uM and 0.8 uM respectively.A pyridazinone derivative and a selective inhibitor of phosphodiesterase type III and IV.

Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 uM and 0.8 uM respectively.A pyridazinone derivative and a selective inhibitor of phosphodiesterase type III and IV.